CIK 0001799448
- Non-accelerated filer
- Smaller reporting company
Aligos Therapeutics, Inc.
Sign in to watch- Ticker
- ALGS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 800-466-6059
- Business address
- ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-09 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +23,310 | 23,310 | ||
| 2025-07-16 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-02-28 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +21,693 | 21,693 | ||
| 2024-09-04 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +10,880 | 10,880 | ||
| 2024-03-01 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +72,000 | 72,000 | ||
| 2024-02-28 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +58,822 | 58,822 | ||
| 2024-02-28 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +74,998 | 74,998 | ||
| 2024-02-28 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +18,750 | 18,750 | ||
| 2024-02-27 | Symons Julian A. See Remarks | Returned to the company · Stock Option (Right to Buy) | −200,000 | 0 | ||
| 2024-02-27 | Symons Julian A. See Remarks | Returned to the company · Stock Option (Right to Buy) | −105,000 | 0 | ||
| 2024-02-27 | Symons Julian A. See Remarks | Returned to the company · Stock Option (Right to Buy) | −26,250 | 0 | ||
| 2023-09-08 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +48,000 | 48,000 | ||
| 2023-03-15 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +78,750 | 78,750 | ||
| 2022-07-07 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-02-04 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2022-02-04 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +26,250 | 26,250 | ||
| 2020-12-01 | Symons Julian A. See Remarks | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2020-10-20 | Symons Julian A. See Remarks | Conversion | +13,671 | 389,218 | ||
| 2020-10-20 | Symons Julian A. See Remarks | Conversion | +3,394 | 392,612 | ||
| 2020-10-20 | Symons Julian A. See Remarks | Conversion | +1,452 | 394,064 |
Page 1 of 2 · 23 trades